TEXTILES.ORG
In a bid to expand the global footprint of its health and wellness applications, Canada-based Myant Corp.,a provider of advanced materials for healthcare, has announced the acquisition of Nanoleq and Osmotex, two leading textile computing companies based in Switzerland. Zurich has now been set up as a base for Myant’s EU and EMEA expansion. These acquisitions add valuable talent to the company and enhance Myant’s lead in textile technologies.
This strategic acquisition strengthens Myant’s mission to pioneer the future of connected health by integrating Nanoleq’s advanced sensor capabilities into its growing portfolio of medical devices. A Swiss company, Nanoleq specializes in smart textiles and biosensing technologies. Both companies share a vision to shift the healthcare paradigm towards prevention, empowering individuals by enabling long-term monitoring through textile computing interfaces and clinical-grade data beyond the hospital setting and into the home.
Nanoleq’s innovative work in the development of stretchable electrical cables, dry electrodes and biosensing technologies culminated in the flagship Oxa device, which enables users to track their respiratory function, ECG, heart rate variability (HRV), and stress levels through its sensor system, providing real-time feedback on vital signs to enhance physical and mental wellbeing.
Myant also acquired the technologies of Swiss company Osmotex, a supplier of advanced technologies for moisture and liquid management in textiles and medicine, following a joint venture phase. For textiles and garments, the technology provides an “electronically controlled, breathable membrane” that can match human sweat rates under the most extreme conditions.
This innovation is set to be a breakthrough for protective gear and first responder garments by acting as a second skin, enhancing physiological comfort, performance and safety for the wearer. In the medical field, Osmotex fabrics will be deployed similarly as a second skin for optimal wound healing and next generation drug delivery systems. Diagnostic applications through fluid sampling, separation and analysis are also being developed.